Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F8Y7R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,432
Award facts
- Contract value 100% obligated
- $25,431.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,431.56 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injector pens. This competitively awarded, firm fixed-price delivery order was issued on December 15, 2025, with completion scheduled for December 16, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical supplier to the DLA's medical supply chain, providing a comprehensive portfolio of pharmaceutical products and medical supplies to support military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The SPE2DX contract functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of brand-name and generic drugs, specialty medications, vaccines, and medical devices to support military healthcare programs worldwide. As a child contract under this prime IDV, the current delivery order for Repatha—a medication used in cardiovascular disease management—represents routine fulfillment of federal medical supply requirements through DLA's established pharmaceutical procurement framework.
Quick answers
Who was awarded contract SPE2DR26F8Y7R?
SPE2DR26F8Y7R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26F8Y7R worth?
The government has obligated $25,432 on SPE2DR26F8Y7R.
Is contract SPE2DR26F8Y7R an order under another contract?
Yes. SPE2DR26F8Y7R is a delivery order under SPE2DR25D1107, an indefinite delivery contract.
Was contract SPE2DR26F8Y7R competed?
The extent of competition for SPE2DR26F8Y7R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award